Cui Y, Yang Y, Tang X, Wang P, Cui J, Chen Y
Front Pharmacol. 2025; 16:1555991.
PMID: 40028160
PMC: 11868102.
DOI: 10.3389/fphar.2025.1555991.
Jiang H, Yang J, Li T, Wang X, Fan Z, Ye Q
Front Pharmacol. 2024; 15:1336102.
PMID: 38495094
PMC: 10940489.
DOI: 10.3389/fphar.2024.1336102.
Cao N, Wang H
Heliyon. 2023; 9(12):e22860.
PMID: 38125490
PMC: 10731081.
DOI: 10.1016/j.heliyon.2023.e22860.
Gao Z, Bao J, Hu Y, Tu J, Ye L, Wang L
Curr Drug Targets. 2023; 24(13):1009-1022.
PMID: 37691190
PMC: 10879742.
DOI: 10.2174/1389450124666230907115831.
Fang Z, Wu G, Sheng J, Ye B, Huang Z, Xu J
Heliyon. 2023; 9(6):e16619.
PMID: 37303505
PMC: 10248119.
DOI: 10.1016/j.heliyon.2023.e16619.
Toll-like receptors in cardiac hypertrophy.
Zhang Y, Wu J, Dong E, Wang Z, Xiao H
Front Cardiovasc Med. 2023; 10:1143583.
PMID: 37113698
PMC: 10126280.
DOI: 10.3389/fcvm.2023.1143583.
The direct effect of lipopolysaccharide on an isolated heart is different from the effect on cardiac myocytes .
Kuo F, Lee S, Cheng J, Wu M
Arch Med Sci. 2023; 19(1):216-228.
PMID: 36817673
PMC: 9897085.
DOI: 10.5114/aoms.2019.86976.
Quercetin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and activation of JAK2/STAT3 pathway: A target based networking pharmacology approach.
Wang D, Ali F, Liu H, Cheng Y, Wu M, Saleem M
Front Pharmacol. 2022; 13:1002363.
PMID: 36324691
PMC: 9618806.
DOI: 10.3389/fphar.2022.1002363.
BRD4 Silencing Protects Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting TLR4/NF-B and Activating Nrf2-HO-1 Pathways.
Fang M, Luo J, Zhu X, Wu Y, Li X
Cardiol Res Pract. 2022; 2022:8372707.
PMID: 36247184
PMC: 9553838.
DOI: 10.1155/2022/8372707.
Silencing of TLR4 Inhibits Atrial Fibrosis and Susceptibility to Atrial Fibrillation via Downregulation of NLRP3-TGF- in Spontaneously Hypertensive Rats.
Ge C, Zhao Y, Liang Y, He Y
Dis Markers. 2022; 2022:2466150.
PMID: 35860690
PMC: 9293556.
DOI: 10.1155/2022/2466150.
Thalidomide Alleviates Pulmonary Fibrosis Induced by Silica in Mice by Inhibiting ER Stress and the TLR4-NF-κB Pathway.
Li Y, Cai W, Jin F, Wang X, Liu W, Li T
Int J Mol Sci. 2022; 23(10).
PMID: 35628464
PMC: 9144898.
DOI: 10.3390/ijms23105656.
Omentin inhibits the resistin-induced hypertrophy of H9c2 cardiomyoblasts by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
Yan X, Wu L, Gao M, Yang P, Yang J, Deng Y
Exp Ther Med. 2022; 23(4):292.
PMID: 35340867
PMC: 8931589.
DOI: 10.3892/etm.2022.11222.
Endothelial-Mesenchymal Transition or Functional Tissue Regeneration - Two Outcomes of Heart Remodeling.
Salingova B, cervenak Z, Adamickova A, Chomanicova N, Valaskova S, Gazova A
Physiol Res. 2021; 70(Suppl 1):S13-S20.
PMID: 34918525
PMC: 8884377.
DOI: 10.33549/physiolres.934780.
Toll-like receptor 4 mutation protects the kidney from Ang-II-induced hypertensive injury.
Majumder S, Pushpakumar S, Juin S, Jala V, Sen U
Pharmacol Res. 2021; 175:106030.
PMID: 34896544
PMC: 8755630.
DOI: 10.1016/j.phrs.2021.106030.
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update.
Verma K, Pant M, Paliwal S, Dwivedi J, Sharma S
Front Pharmacol. 2021; 12:734917.
PMID: 34489714
PMC: 8417791.
DOI: 10.3389/fphar.2021.734917.
DL-3-n-Butylphthalide Attenuates Myocardial Hypertrophy by Targeting Gasdermin D and Inhibiting Gasdermin D Mediated Inflammation.
Han B, Xu J, Shi X, Zheng Z, Shi F, Jiang F
Front Pharmacol. 2021; 12:688140.
PMID: 34168567
PMC: 8217660.
DOI: 10.3389/fphar.2021.688140.
IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway.
Kang M, Lee J, Lee C, Park H, Jang K, Park S
J Pers Med. 2021; 11(4).
PMID: 33917914
PMC: 8068290.
DOI: 10.3390/jpm11040284.
Matrix metalloproteinase 3 regulates angiotensin II‑induced myocardial fibrosis cell viability, migration and apoptosis.
Shu J, Gu Y, Jin L, Wang H
Mol Med Rep. 2021; 23(2).
PMID: 33655326
PMC: 7789094.
DOI: 10.3892/mmr.2020.11790.
Angiotensin II blockers improve cardiac coronary flow under hemodynamic pressure overload.
Chang W, Fisch S, Dangwal S, Chen M, Cheng S, Chen Z
Hypertens Res. 2021; 44(7):803-812.
PMID: 33568793
PMC: 8260442.
DOI: 10.1038/s41440-021-00617-1.
TLR4 regulates vascular smooth muscle cell proliferation in hypertension via modulation of the NLRP3 inflammasome.
Qi H, Cao Q, Liu Q
Am J Transl Res. 2021; 13(1):314-325.
PMID: 33527026
PMC: 7847527.